Geode Capital Management, LLC Gossamer Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,555,080 shares of GOSS stock, worth $8.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,555,080
Previous 2,272,448
100.45%
Holding current value
$8.79 Million
Previous $2.5 Million
124.17%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding GOSS
# of Institutions
135Shares Held
159MCall Options Held
2.84MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...